Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
UTAH MEDICAL PRODUCTS INC
Utah Medical Products (UTMD) reported a 12.1% year-over-year decline in Q3 2026 revenue to $8.62 million, driven by the loss of major customers and lower sales of the Filshie Clip System. The company projects a total revenue decline of approximately 7% for the full year 2026. Despite lower revenue, Q3 operating income rose 7% to $2.795 million, primarily due to reduced litigation expenses and the completion of intangible asset amortization.…more
UTAH MEDICAL PRODUCTS INC
Utah Medical Products (UTMD) has extended the expiration date of its tender offer to purchase 650,000 shares of its common stock at $75.00 per share from October 7, 2026, to October 27, 2026. Shareholders may continue to tender their shares under the terms of the offer until the new deadline.…more
UTAH MEDICAL PRODUCTS INC
Utah Medical Products (UTMD) has announced a tender offer to repurchase up to 650,000 shares of its common stock at a price of $75.00 per share. The offer is scheduled to expire on October 7, 2026, and is intended to enhance shareholder value and improve capital efficiency by reducing the number of outstanding shares.…more
8 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Utah Medical Products Q3 EPS Rises, Revenue Declines
Utah Medical Products reported a Q3 EPS of $0.88, marking a 7.32% increase compared to the same period last year. However, quarterly revenue fell by 12.14% to $8.621 million, indicating a decline in top-line growth.…more
●●●●●●●● ●●●●● ●●●●●●
Utah Medical Products announced a tender offer to repurchase up to 650,000 shares of its common stock at a price of $75.00 per share. The offer is scheduled to commence on September 22.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.